No. 22-17

Vaxima, Inc., et al. v. United States

Lower Court: Fourth Circuit
Docketed: 2022-07-06
Status: Denied
Type: Paid
Response Waived
Tags: 28-usc-2461 breach-of-contract criminal-conviction criminal-forfeiture honeycutt-decision honeycutt-v-united-states indictment statutory-interpretation
Key Terms:
Environmental SocialSecurity Securities Immigration
Latest Conference: 2022-09-28
Question Presented (AI Summary)

Whether a criminal forfeiture judgment against Petitioners is permitted under Honeycutt

Question Presented (OCR Extract)

QUESTIONS PRESENTED 1. Whether a criminal forfeiture judgment against Petitioners Vaxima, Inc. and GenPhar, Inc. (collectively “Petitioners”) under 28 U.S.C. § 2461(c), is permitted under this Court’s decision in Honeycutt v. United States, 1387S. Ct. 1626 (2017) (“Honeycutt”). 2. Whether a criminal conviction can be supported by an indictment alleging that Petitioners’ conduct amounted to breach of contract.

Docket Entries

2022-10-03
Petition DENIED.
2022-07-20
DISTRIBUTED for Conference of 9/28/2022.
2022-07-13
Waiver of right of respondent United States to respond filed.
2022-06-25
Petition for a writ of certiorari filed. (Response due August 5, 2022)

Attorneys

United States
Elizabeth B. PrelogarSolicitor General, Respondent
Elizabeth B. PrelogarSolicitor General, Respondent
Vaxima, Inc., et al.
Robert Edward BarnesBarnes law, Petitioner
Robert Edward BarnesBarnes law, Petitioner